Latest Options News

Patronus Resources has upgraded its Mertondale Gold Project resource estimate, increasing contained gold ounces to 480,000oz alongside an 18% rise in grade, setting the stage for a June 2025 scoping study.

Osteopore Limited has announced a $20 million convertible notes offering aimed at bolstering its capital for ongoing operations and future projects. The highly speculative offer targets sophisticated investors and underscores the company’s strategic funding approach amid competitive medical device markets.

Bridge SaaS Limited has appointed Richard Gordon as CEO, signaling a strategic push to expand its footprint in the NDIS sector through acquisitions and technology innovation.

Vitura Health has raised $5.1 million from prominent investor Professor Khalil Shahin, marking a significant step towards acquiring Candor Medical and accelerating its digital health expansion.

AGL Energy reported solid FY25 half-year results with underlying EBITDA of $1.068 billion and narrowed guidance, underscoring its commitment to a sustainable energy transition through significant investments in grid-scale batteries and renewables.

DEXUS Industria REIT has finalized its quarterly distribution at AUD 0.041 per security for the period ending December 31, 2024, with payments scheduled for February 20, 2025.

Evolution Mining has reported a landmark first half of FY25 with a 277% jump in statutory net profit and a substantial 250% increase in its interim dividend, underscoring robust operational momentum and shareholder returns.

St Barbara Limited has announced its intention to separate its Atlantic Gold Operations in Nova Scotia, aiming to unlock value through a Canadian-led development while concentrating on its Papua New Guinea assets.

Suncorp Group Limited has announced a combined ordinary and special dividend totaling AUD 0.63 per security, fully franked and backed by APRA approval for a capital reduction. The payment is scheduled for mid-March 2025.

Genesis Energy and New Zealand’s top generators are exploring extending Huntly Power Station’s life to address supply risks highlighted by winter 2024’s energy crunch.

Commonwealth Bank of Australia announces a fully franked ordinary dividend of AUD 2.25 per share, payable March 28, 2025, reflecting solid financial results for the period ending December 31, 2024.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.